New Data Presented at World Muscle Society Congress Support Potential Benefit of Investigational Treatment Nusinersen in Spinal Muscular Atrophy
CAMBRIDGE, Mass. & CARLSBAD, Calif.–(BUSINESS WIRE)– New data from the clinical program for nusinersen, an investigational treatment for spinal muscular atrophy (SMA), were presented by...